Michael A. Metzger - Jul 16, 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael A. Metzger
Stock symbol
SNDX
Transactions as of
Jul 16, 2025
Transactions value $
-$69,953
Form type
4
Date filed
7/18/2025, 04:30 PM
Previous filing
Apr 2, 2025
Next filing
Sep 8, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Metzger Michael A Chief Executive Officer, Director C/O SYNDAX PHARMACEUTICALS, INC., 730 3RD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger 2025-07-18 0001507220

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Sale -$70K -7.53K -2.46% $9.29 299K Jul 16, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.